InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,572.85
(
0.10%
)
US TECH 100
19,964.40
(
0.36%
)
Dow Jones
39,344.79
(
-0.08%
)
Brent Oil
85.08
(
-0.40%
)
Bitcoin
57,646.90
(
1.66%
)
Post# of 252525
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 831
Posts 119993
Boards Moderated 17
Alias Born 09/05/2002

DewDiligence

Member Level

Re: genisi post# 101170

Tuesday, 08/10/2010 11:27:51 AM

Tuesday, August 10, 2010 11:27:51 AM

Post# of 252525

VRTX—Strange (in the sense that it is opposed to what I'd expect) that patients in the shorter treatment arm had higher SVR rate but higher relapse rate than the longer 48 weeks arm.

The higher SVR rate in the 24-week arm on an ITT basis is explained by fewer dropouts compared to the 48-week arm, which is exactly what one would expect.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up